Genpharmasec Limited (GENPHARMA) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE861N01036
Key metrics
- Market Cap
- ₹69 Cr
- P/E Ratio
- 41.33
- EPS
- -0.01
- Book Value
- 1.19
- P/B Ratio
- 1.04
- ROE
- 2.44%
- ROCE
- -0.94%
- Debt / Equity
- 0.53
- Net Margin
- 1.15%
- Revenue Growth
- 314.98%
- Profit Growth
- 1.09%
- Dividend Yield
- —
- 52W High
- ₹2.15
- 52W Low
- ₹0.76
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Genpharmasec Limited
Genpharmasec Limited buys, sells, and distributes pharmaceutical activities and services in India. The company operates through two segments, Diagnostic Pharma Equipment, and Investment and Trading in Securities. The Diagnostic Pharma Equipment segment distributes state-of-the-art diagnostic equipment comprising of i-STAT analyzers and its cartridges used to analyze blood for test results in Intensive Care Units (ICUs) of hospitals. The Investment and Trading in Securities segment operates in secondary securities market. The company was formerly known as Generic Pharmasec Limited and changed its name to Genpharmasec Limited in October 2021. Genpharmasec Limited was incorporated in 1992 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 43.91%
The full Genpharmasec Limited analysis
Create a free account to open the complete GENPHARMA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.